Ryan Murr - MergerLinks

AcquisitionMergerMajorityPublicDomestic

target

Zyla Life Sciences

bidder

Assertio Therapeutics

£85m

28 dealmakers

PrivateAcquisitionPrivate EquityVenture CapitalMinority

target

Shattuck Labs

bidder

Hatteras Venture Partners

£94m

15 dealmakers

PublicMergerTender OfferMajority

target

Tetraphase Pharmaceuticals

bidder

La Jolla Pharmaceutical

£47m

7 dealmakers

AcquisitionMergerPrivateMajority

target

Kiq

bidder

Unum Therapeutics

value n/a

13 dealmakers

MajorityPrivateDomesticAcquisition

target

Anelixis Therapeutics

bidder

Novus Therapeutics

value n/a

4 dealmakers

DomesticMajorityPrivateAcquisitionReverse TakeoverMerger

target

Quellis Biosciences

bidder

Catabasis Pharmaceuticals

value n/a

23 dealmakers

Switzerland

De-SPACAcquisitionPrivateReverse TakeoverMergerCross Border

target

Moonlake Immunotherapeutics

bidder

Bvf Partners

£169m

44 dealmakers

AcquisitionDomesticPublicMajority

Medical Equipment

target

Ortho Clinical Diagnostics

bidder

Quidel Corporation

£6,011m

61 dealmakers

MajorityPrivateCross BorderAcquisition

target

Atara Biotherapeutics (t-cell Facility)

bidder

Fujifilm Holdings Corp

£74m

8 dealmakers

DomesticMajorityPublicAcquisition

target

La Jolla Pharmaceutical

bidder

Innoviva

£124m

12 dealmakers

PrivateAcquisitionDomesticMajority

target

PALAMEDRIX

bidder

SOMALOGIC

£43m

7 dealmakers

PublicMajorityReverse TakeoverMergerDomesticAcquisition

target

Enliven Therapeutics

bidder

IMARA

value n/a

41 dealmakers

AcquisitionPrivatePrivate EquityMinorityVenture CapitalDomestic

target

Apogee Therapeutics

bidder

Perceptive Advisors

£122m

3 dealmakers

PrivateDomesticPrivate EquityDe-SPACAcquisitionMajorityReverse Takeover

Health Care Services

target

Allurion Technologies

bidder

Compute Health Acquisition Corp

£414m

14 dealmakers

MajorityAcquisitionDomesticPrivate EquityPublic

target

Jounce Therapeutics

bidder

Concentra Health Services

£78m

11 dealmakers

MinorityPrivate EquityAcquisitionDomesticPublic

target

Milestone Pharmaceuticals

bidder

Rtw Investments

£100m

4 dealmakers

MajorityDomesticMergerAcquisitionPrivate

Medical Services

target

Dianthus Therapeutics

bidder

Magenta Therapeutics

value n/a

7 dealmakers

Tender OfferCross BorderMajorityPublicAcquisitionPrivate Equity

target

Cti Biopharma

bidder

Swedish Orphan Biovitrum (sobi)

£1,347m

76 dealmakers

MinorityCross BorderVenture CapitalAcquisitionPrivate EquityPrivate

target

CULLGEN

bidder

Astrazeneca-cicc Venture Capital Partnership

£32m

3 dealmakers

DomesticMergerAcquisitionMajorityPublic

target

Cohbar

bidder

Morphogenesis

£12m

4 dealmakers

AcquisitionMajorityPrivateDomesticReverse Takeover

target

Spyre Therapeutics

bidder

Aeglea Biotherapeutics

£86m

17 dealmakers

AcquisitionDomesticMajorityMergerPublic

target

Neoleukin Therapeutics

bidder

Neurogene

£282m

6 dealmakers

DomesticAcquisitionMinorityPrivate EquityPublic

target

VERASTEM

bidder

Bvf Partners

£48m

4 dealmakers

AcquisitionDomesticPublicMajority

target

Rain Oncology

bidder

Pathos Ai

value n/a

33 dealmakers